Quality Colostrum Products for Health Professionals    



 

PROSymbiotics™  News!
FDA News

 PROSYMBIOTICS HEADLINES

FDA News

In an official comment submitted to the Federal Drug Administration on April 19, 2000, Symbiotics and regulatory counsel recommended that a distinction be made between making health claims to physicians and pharmacists and making them to ordinary customers.

The usage of dietary supplements by consumers has increased significantly in the last few years, creating a need for physicians and pharmacists to incorporate supplements into their practices and stores. In addition, many consumers look to health professionals to supply them with education and product information on dietary supplements. Because the supplement industry is so vast and encompasses such a diverse number of products, it would be ludicrous to expect health professionals to have a working understanding of all of the clinical relevance, side effects, contraindications or pharmacokinetics of every product available. Alternatively, marketers of supplements spend a great deal of time and money substantiating product claims through scientific literature and ensuring that each product is safe and effective through independent quality testing. Supplement marketers have strong incentives to provide physicians and pharmacists with educational material regarding the benefits of their products, however the FDA policy does not delineate between health professionals and ordinary consumers. This does not bode well for the physician or pharmacist who must perform an intensive search of the scientific research each time a patient or customer inquires about a new supplement.

In light of this, Symbiotics, Inc. is asking the FDA to consider permitting the use of health claims to be made in labeling and educational collateral directed to health professionals so long as they are accompanied by full research citations to peer reviewed scientific literature. If this information was displayed prominently on the marketing materials, it would allow physicians or pharmacists to quickly screen each supplement and decrease their search costs and time. This would greatly enhance the continued education of health professionals and subsequently, positively effecting patient care.

Symbiotics, Inc. contends that physicians and pharmacists are amply trained to evaluate scientific literature critically, and therefore do not require the same degree of regulation on dietary supplement health claims as do ordinary consumers, who may not be able to discern the basis or lack thereof for the claim.

It seems necessary to provide health professionals with a higher degree of information on product ingredients, and the health claims associated with those ingredients. Ultimately, the responsibility of educating the consumer lies in the hands of the health professional, and it is our obligation at Symbiotics, Inc. to educate physicians and pharmacists.


<-- back


PROSymbiotics

The statements made in this document have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent disease.
© Symbiotics, Inc. 2000-2005  |  privacy policy